XML 40 R32.htm IDEA: XBRL DOCUMENT v3.25.2
Stock Based Compensation (Tables)
6 Months Ended
Jun. 30, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Recognized Stock Based Compensation

For the three and six months ended June 30, 2025 and 2024, the Company recognized stock-based compensation expense as follows:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(Amounts in 000’s)

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Employee compensation:

 

 

 

 

 

 

 

 

 

 

 

 

Stock compensation expense

 

$

25

 

 

$

23

 

 

$

47

 

 

$

66

 

Total employee stock-based compensation expense

 

$

25

 

 

$

23

 

 

$

47

 

 

$

66

 

 

Summary of Company's Restricted Stock Activity

The following table summarizes the Company's restricted stock activity for the six months ended June 30, 2025:

 

 

Number of
Shares (000's)

 

 

Weighted Avg.
Grant Date
(per Share)
Fair Value

 

Unvested, December 31, 2024

 

 

86

 

 

$

2.61

 

Granted

 

 

65

 

 

$

2.60

 

Vested

 

 

(33

)

 

$

2.74

 

Unvested, June 30, 2025

 

 

118

 

 

$

2.57

 

There were 65,000
Summary of Company's Stock Option Activity

The following summarizes the Company's employee and non-employee stock option activity for the six months ended June 30, 2025:

 

 

Number of
Shares (000's)

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value (000's)

 

Outstanding, December 31, 2024

 

 

48

 

 

$

2.68

 

 

 

8.5

 

 

$

 

Exercised

 

 

(48

)

 

$

2.68

 

 

 

 

 

 

 

Outstanding, June 30, 2025

 

 

 

 

$

 

 

 

 

 

$

 

No stock options were granted for the six months ended June 30, 2025. All vested stock options were exercised during the six months ended June 30, 2025; thus, there are no outstanding stock options as of June 30, 2025.

Warrant [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Warrant Activity

The following summarizes the Company's warrant activity for the six months ended June 30, 2025:

 

 

Outstanding and Exercisable

 

 

 

 

 

 

Number of
Shares (000's)

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in 000's)

 

Outstanding, December 31, 2024

 

 

15

 

 

$

51.00

 

 

 

0.2

 

 

$

 

Expired

 

 

(15

)

 

$

51.00

 

 

 

 

 

 

 

Outstanding, June 30, 2025

 

 

 

 

$

 

 

 

 

 

$